Effectiveness and Adherence of Nutritional Management via Electronic Patient-Reported Outcomes Platform in Patients With Cancer: Multicenter Prospective Longitudinal Cohort Study.
Article in JMIR cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
24 authors.
Jiaxin Huang *Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0000-0002-4004-0424
Si-Wei Xie *Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, United States.ORCID 0009-0000-1602-2296
Le Tian *Comprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0000-0001-6244-3956
Hui-Min QuDepartment of Medicine, Gesi (Hebei) Medical Research Institute, Langfang, China.ORCID 0009-0005-4061-4837
Xi ZhangComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0000-0002-3869-3856
Zhi-Gang FengDepartment of Medicine, Gesi (Hebei) Medical Research Institute, Langfang, China.ORCID 0009-0003-0313-6536
Xin-Yi WangDepartment of Medicine, Gesi (Hebei) Medical Research Institute, Langfang, China.ORCID 0009-0007-4798-419X
Ming-Hui ZhangDepartment of Oncology, Chifeng Municipal Hospital, Chifeng, China.ORCID 0009-0003-4888-3981
Shu-Qing WeiDepartment of General Internal Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.ORCID 0009-0006-1566-0222
Jun LiRadiotherapy Department and Nutrition Department, Mianyang Cancer Hospital, Mianyang, China.ORCID 0009-0005-1830-2327
Li-Li HongDepartment of Oncology, Tianjin Huanghe Hospital, Tianjin, China.ORCID 0009-0006-1344-9028
Wen-Hui YangDepartment of General Internal Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.ORCID 0000-0002-1452-6789
Wen-Hao HuDepartment of General Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.ORCID 0009-0007-4460-8199
Qian-Tong DongDepartment of General Surgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.ORCID 0000-0003-0109-0792
Ning LiComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0000-0002-7285-246X
Min YangComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0000-0002-6836-3137
Meng TangComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0000-0003-0561-2906
Chen-Xin SongComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0009-0009-7306-5140
Bao-Hua ZouComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0000-0001-8294-0634
Sheng-Ling QinComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0009-0003-2068-6628
Rong QinComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0009-0002-2845-1500
Minghua CongComprehensive Oncology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17, Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China, 86 15001048699.ORCID 0000-0002-1082-9598
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Background: Personalized nutritional management during cancer remains challenging in clinical practice. The development of an electronic patient-reported outcome platform (ePROM) provides novel opportunities. Objective: This study aimed to evaluate the effectiveness and adherence of nutritional management using ePROM in patients with cancer. Methods: This multicenter prospective longitudinal cohort study included 6124 patients diagnosed with cancer. Exposure was defined as adherence to the ePROM journal, measured by the longest consecutive month of weekly entries. Dietary intake was reported via food selection, voice input, or meal photos. The primary outcomes were adequate energy intake (EI, ≥25 kcal/kg/day) and protein intake (PI, ≥1 g/kg/day), defined according to European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines. Logistic regression analysis was conducted to identify the factors associated with EI and PI, reporting odds ratios (ORs) and 95% CIs. A restricted cubic spline plot was used to illustrate the association between the adjusted ORs and adherence duration. The semMediation approach was applied to assess the impact of multiple mediators on the outcomes. Results: The study cohort comprised 3741/6124 (61.1%) men and 2383 (38.9%) women, with a median age of 60.85 (IQR 53.3-68.3) years. Overall, 1024/6124 (16.7%) and 2591/6124 (42.3%) patients achieved adequate EI and PI scores, respectively. At one month, 499/1024 patients (48.7%) in the adequate EI group and 1287/2591 (49.7%) in the adequate PI group continued journaling, compared with 1879/5100 (36.8%) and 1091/3533 (30.9%) in the corresponding inadequate groups (P<.001). This trend remained significant in the second, third, and sixth months. Logistic regression analysis demonstrated that longer adherence to ePROM journaling was independently associated with adequate EI (OR 1.05, 95% CI 1.01-1.08; P=.01) and PI (OR 1.22, 95% CI 1.16-1.28; P<.001) after adjusting for confounders. Mediation analysis revealed that most symptoms did not significantly mediate these effects, except for constipation, reflux, and delirium, which showed statistical significance but minimal indirect effects. Conclusions: Nutritional management via ePROM is a feasible approach, with improved effectiveness as adherence duration increases. The observed benefits resulted primarily from direct effects rather than from symptom improvement.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Effectiveness and Adherence of Nutritional Management via Electronic Patient-Reported Outcomes Platform in Patients With Cancer: Multicenter Prospective Longitudinal Cohort Study. · full record | OpenQuestion